Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Notice of meeting.

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Mine Safety and Health Research Advisory Committee (MSHRAC). This is a hybrid meeting, accessible both in person and virtually. It is open to the public and limited only by the space available and the number of web conference lines available. Time will be available for public comment.

# DATES:

The meeting will be held on April 17, 2024, from 8:30 a.m. to 4:10 p.m., EDT.

# ADDRESSES:

Mine Safety and Heath Administration's Approval and Certification Center, 765 Technology Drive, Triadelphia, West Virginia 26059. The conference room accommodates approximately 49 people.

Please note that the meeting location is a Federal facility and in-person access is limited to U.S. citizens unless prior authorizations, taking up to 30 to 60 days, have been made.

                        If you wish to attend the meeting either in person or virtually, please contact Ms. Berni Metzger by email at                         *Metzger@cdc.gov*                         or by phone at (412) 386-4541 at least 5 business days in advance of the meeting. If you are attending virtually, she will provide you with the Zoom web conference access information (500 web conference lines are available).                    

# FOR FURTHER INFORMATION CONTACT:

                        Steven Mischler, Ph.D., Designated Federal Officer, Mine Safety and Health                               ( print page 15580)                            Research Advisory Committee, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 626 Cochrans Mill Road, Pittsburgh, Pennsylvania 15236. Telephone: (412) 386-5688; Email:                         *SMischler@cdc.gov.*

# SUPPLEMENTARY INFORMATION:

*Purpose:*                     The Mine Safety and Health Research Advisory Committee is charged with providing advice to the Secretary, Department of Health and Human Services; the Director, Centers for Disease Control and Prevention; and the Director, National Institute for Occupational Safety and Health (NIOSH), on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2).                

*Matters To Be Considered:*                     The agenda will include discussions on NIOSH mining safety and health research organizational structure, capabilities, projects, and outcomes, as well as a verbal report from the Mace Development Workgroup. The meeting will also include an update from the NIOSH Associate Deputy Director, Mine Safety and Research. Agenda items are subject to change as priorities dictate.                

## Public Participation

*Written Public Comment:*                     The public may submit written comments or questions in advance of the meeting, to the Designated Federal Officer (see                     **FOR FURTHER INFORMATION CONTACT**                     above). Written comments received in advance of the meeting will be included in the official record of the meeting, and questions will be answered during the oral comment period open to public participation.                

*Oral Public Comment:*                     The meeting will include time for members of the public to make an oral comment. The public comment session will be held on April 17, 2024, at 3:30 p.m., EDT, or the conclusion of the planned presentations, whichever comes first. Members of the public will be allocated 5 to 10 minutes each for presentations or comments, as a function of the number of commenters.                

                    The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. 

[FR Doc. 2024-04433 Filed 3-1-24; 8:45 am]

BILLING CODE 4163-18-P